Home/Filings/4/0001209191-22-000122
4//SEC Filing

Halkias Theodore 4

Accession 0001209191-22-000122

CIK 0001831097other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:03 PM ET

Size

15.3 KB

Accession

0001209191-22-000122

Insider Transaction Report

Form 4
Period: 2021-12-30
Halkias Theodore
Chief Business Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-12-30$1.00/sh+12,113$12,11317,547 total
  • Sale

    Common Stock

    2021-12-30$27.54/sh12,113$333,5925,434 total
  • Exercise/Conversion

    Options (Rights to Buy)

    2021-12-3012,1131,702,609 total
    Exercise: $1.00Exp: 2027-04-27Common Stock (12,113 underlying)
  • Exercise/Conversion

    Options (Rights to Buy)

    2021-12-311,1621,701,447 total
    Exercise: $1.00Exp: 2027-04-27Common Stock (1,162 underlying)
  • Exercise/Conversion

    Common Stock

    2021-12-31$1.00/sh+1,162$1,1626,596 total
  • Sale

    Common Stock

    2021-12-31$27.55/sh1,162$32,0135,434 total
Footnotes (5)
  • [F1]Includes restricted stock units.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F5]These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021.

Issuer

agilon health, inc.

CIK 0001831097

Entity typeother

Related Parties

1
  • filerCIK 0001855972

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:03 PM ET
Size
15.3 KB